Chamber and committees

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

Written questions must be answered within 10 working days (20 working days during recess)
Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Filter your results Hide all filters

Displaying 45751 questions Show Answers

Order by |

Question reference: S6W-15108

Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
Date lodged: Thursday, 16 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what recent assessment NHS Scotland has made of the estimated costs of running hospital equipment at home.

Question reference: S6W-15087

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 16 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what specific support it is providing to staff employed by the Glasgow Lighthouse Lab who are at risk of redundancy.

Scottish Government Officials have had contact with representatives of the University of Glasgow and met with representatives of UNITE on 10 January to discuss recent developments in respect of the Glasgow Lighthouse Lab which is contracted by the UK Government until March 2023 to undertake processing of PCR tests as part of the COVID-19 Infection Survey (CIS). The CIS is outwith the control of the Scottish Government.

The Scottish Government has provided support to affected University of Glasgow staff through its Partnership Action for Continuing Employment (PACE) initiative and will continue to provide such support to any impacted staff as may be required.

Question reference: S6W-15080

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Thursday, 16 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what it anticipates the impact will be on NHS Scotland laboratory transformation of the 19.4% reduction in genomics funding, as set out in the draft Budget 2023-24.

Following the 22-23 Emergency Budget Review genomics was allocated a revised budget of £5 million; this provided a £2.6 million increase on 22-21 funding. Therefore, the £5million budget allocation for genomics in 2023-24 represents a sustained investment in genomics.

Through the funding allocated so far in 2022-23, we have established the Scottish Strategic Network for Genomic Medicine and funded a genomics transformation team within NHS National Services Division, led by a Consultant Clinical Scientist and supported by Clinical Leads for rare disease and cancer.

The fiscal position remains challenging; however the development of our transformation plans for the NHS Genetic Laboratories and Genomics Strategy is ongoing.

To support this, the Transformation Team are developing an action plan in response to the NSS Major Services Review of Genetic services . The Strategic Network will be accountable for overseeing the delivery of that plan.

Question reference: S6W-15139

Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
Date lodged: Thursday, 16 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what steps it is taking to improve outcomes for patients with inflammatory bowel disease.

Scottish Government has funded Modernising Patient Pathways Programme (MPPP) which has a specific workstream continuing to promote improvements in Inflammatory Bowel Disease (IBD) care for patients across Scotland in partnership with third-sector and people with lived experience. Scotland’s national IBD Steering Group has identified priority areas for work over the next two years. This includes consideration of referral pathways and models of IBD care to drive a more standardised and equitable service across Scotland.

Question reference: S6W-15061

Asked by: Katy Clark, MSP for West Scotland, Scottish Labour
Date lodged: Thursday, 16 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what the current average length of time is for which agreed interim care placements are in place, broken down by local authority area.

Question reference: S6W-15140

Asked by: Miles Briggs, MSP for Lothian, Scottish Conservative and Unionist Party
Date lodged: Thursday, 16 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government how many people with inflammatory bowel disease (IBD) presented at A&E due to an IBD flare-up in 2022.

Question reference: S6W-15081

Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
Date lodged: Wednesday, 15 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what impact assessment has been carried out to examine the potential impact on NHS Scotland laboratory transformation of the 19.4% reduction in genomics funding, as set out in the draft Budget 2023-24.

As a result of the 22-23 Emergency Budget Review genomics was allocated a revised budget of £5 million, which has been sustained for 23-24.

Neither the Scottish Government nor the Scottish Strategic Network for Genomic Medicine has carried out any specific impact assessments in relation to genomics. However the draft budget was published alongside an equalities impact assessment, high level carbon assessment and an analytical report on the Impact the Cost of Living Crisis is having in Scotland. All of this material can be found online via the following link.

Scottish Budget - gov.scot (www.gov.scot)

The fiscal position remains challenging; however, the development of our transformation plans for the NHS Genetic Laboratories and Genomics Strategy is ongoing.

Question reference: S6W-14917

Asked by: Maurice Golden, MSP for North East Scotland, Scottish Conservative and Unionist Party
Date lodged: Friday, 10 February 2023
Current Status: Answered by Lorna Slater on 10 March 2023

To ask the Scottish Government, further to the answer to question S6W-14359 by Lorna Slater on 7 February 2023, which states that the "Deposit Return Scheme is an industry-led scheme, delivered by industry, led by the scheme administrator, Circularity Scotland Ltd”, whether it is the case that industry can change the launch date of the scheme, and, if so, by what process.

Question reference: S6W-14718

Asked by: Rachael Hamilton, MSP for Ettrick, Roxburgh and Berwickshire, Scottish Conservative and Unionist Party
Date lodged: Monday, 06 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what assessment it has made regarding the effect of staff vacancies on the performance and safety of homecare medicine services.

There were significant capacity constraints across the medicines homecare market in 2022. A key challenge has been recruitment of staff in a challenging labour market, with some providers more adversely affected than others. The situation is improving but continues to be closely monitored.

Certain homecare providers have highlighted issues with nursing capacity in recent months. Where this has been raised as an issue, there has been close working with providers to ensure that available staffing resource is used in a way that helps minimise disruption to service performance.

Homecare providers have not reported any recent issues with staffing within their pharmacy departments.

Several homecare providers have experienced staffing shortages within customer services departments, and this has been a major contributing factor to the capacity constraints experienced.

There have been a small number of instances where there have been delays to the delivery of medicines to patients, which has the potential to impact on patient safety. Medicines homecare providers and Health boards have processes in place to support managing and learning from any patient safety incidents that arise during service delivery.

Question reference: S6W-14716

Asked by: Rachael Hamilton, MSP for Ettrick, Roxburgh and Berwickshire, Scottish Conservative and Unionist Party
Date lodged: Monday, 06 February 2023
Current Status: Answered by Humza Yousaf on 10 March 2023

To ask the Scottish Government what the average waiting time is (a) in the Scottish Borders and (b) nationally for rheumatology patients to receive treatment by homecare medicines services.